Koliopoulos
J, Theodosiasdis
G. Retinal detachment and acquired colour vision disturbance. Mod Probl Ophthalmol. 1972;11117- 121
Drum
B, Armaly
MF, Huppert
WE. Sources of short wavelength sensitivity loss in glaucoma. Doc Ophthalmol Proc Ser. 1987;46413- 422
Gastaud
P, Vola
J, Saracco
JB, de Galleani
B, Costet
C. Diabetic dyschromatopsia: pathogenic hypothesis. Doc Ophthalmol Proc Ser. 1987;46387- 390
Hood
DC, Benimoff
WI, Greenstein
VC. The response range of the blue-cone pathways: a source of vulnerability to disease. Invest Ophthalmol Vis Sci. 1984;25864- 867
Gündüz
K, Arden
GB, Perry
S, Weinstein
GW, Hitchings
RA. Color vision defects in ocular hypertension and glaucoma: quantification with a computer-driven color television system. Arch Ophthalmol. 1988;106929- 935
Mollon
JD. What is odd about the short-wavelength mechanism and why is it disproportionately vulnerable to acquired damage? report of a discussion. Doc Ophthalmol Proc Ser. 1983;33145- 149
Farnsworth
D. Tritanomalous vision as a threshold function. Farbe. 1955;4185- 197
Greenstein
V, Hood
DC, Campbell
CJ. The use of a flash-on-flash paradigm to assess sensitivity changes due to retinal disease. Invest Ophthalmol Vis Sci. 1982;23102- 112
Osterberg
GA. Topology of the layer of rods and cones in the human retina. Acta Ophthalmol Suppl. 1935;61- 103
Marc
RE, Sperling
HG. Chromatic organization of primate cones. Science. 1977;196454- 456
Sperling
HG, Johnson
C, Harwerth
RS. Differential spectral photic damage to primate cones. Vision Res. 1980;201117- 1125
de Monasterio
FM, Schein
SJ, McCrane
EP. Staining of blue-sensitive cones of the macaque retina by a fluorescent dye. Science. 1981;2131278- 1281
de Monasterio
FM, McCrane
EP, Newlander
JK, Schein
SJ. Density profile of blue-sensitive cones along the horizontal meridian of macaque retina. Invest Ophthalmol Vis Sci. 1985;26289- 302
Ahnelt
PK, Kolb
H, Pflug
R. Identification of a subtype of cone photoreceptor, likely to be blue sensitive, in the human retina. J Comp Neurol. 1987;25518- 34
Nork
TM, McCormick
SA, Chao
GM, Odom
JV. Distribution of carbonic anhydrase among human photoreceptors. Invest Ophthalmol Vis Sci. 1990;311451- 1458
Hart
WMJ, Burde
RM. Three-dimensional topography of the central visual field: sparing of foveal sensitivity in macular disease. Ophthalmology. 1983;901028- 1038
Hart
WMJ. Color contrast perimetry: hue discrimination defects in acquired dyschromatopsias. Doc Ophthalmol Proc Ser. 1987;46267- 273
Hart
WMJ. Acquired dyschromatopsias. Surv Ophthalmol. 1987;3210- 31
Hurvich
LM, Jameson
D. Some quantitative aspects of an opponent-colors theory, II: brightness, saturation, and hue in normal and dichromatic vision. J Opt Soc Am. 1955;45602- 616
Derrington
AM, Krauskopf
J, Lennie
P. Chromatic mechanisms in lateral geniculate nucleus of macaque. J Physiol (Lond). 1984;357241- 265
Kaiser
PK, Boynton
RM. Human Color Vision. 2nd ed. Washington, DC Optical Society of America1996;250- 253
Nathans
J, Thomas
D, Hogness
DS. Molecular genetics of human color vision: the genes encoding blue, green and red pigments. Science. 1986;232193- 202
Szél
Á, Takács
L, Monostori
É, Diamantstein
T, Vigh-Teichmann
I, Röhlich
P. Monoclonal antibody-recognizing cone visual pigment. Exp Eye Res. 1986;43871- 883
Johnson
LV, Hageman
GS. Characterization of molecules bound by the cone photoreceptor-specific monoclonal antibody CSA-1. Invest Ophthalmol Vis Sci. 1988;29550- 557
Nork
TM, Mangini
NJ, Millecchia
LL. Rods and cones contain antigenically distinctive S-antigens. Invest Ophthalmol Vis Sci. 1993;342918- 2925
Nork
TM, Millecchia
LL, Strickland
BD, Linberg
JV, Chao
GM. Selective loss of blue cones and rods in human retinal detachment. Arch Ophthalmol. 1995;1131066- 1073
Nork
TM. Acquired color vision loss and a possible mechanism of ganglion cell death in glaucoma. Trans Am Ophthalmol Soc.
Nork
TM, Ver Hoeve
JN, Poulsen
GL.
et al. Swelling and loss of photoreceptors in chronic human and experimental glaucomas. Arch Ophthalmol. 2000;118235- 245
Diabetic Retinopathy Study Research Group,
Photocoagulation treatment of diabetic retinopathy: clinical application of diabetic retinopathy study (DRS) findings: DRS-report No. 8. Ophthalmology. 1981;88583- 600
Verriest
G. Further studies on acquired deficiency of color discrimination. J Opt Soc Am. 1963;53185- 195
Adams
AJ, Zisman
F, Ai
E, Bresnick
G. Macular edema reduces B cone sensitivity in diabetics. Appl Opt. 1987;261455- 1457
Greenstein
VC, Hood
DC, Ritch
R, Steinberger
D, Carr
RE. S-(blue) cone pathway vulnerability in retinitis pigmentosa, diabetes and glaucoma. Invest Ophthalmol Vis Sci. 1989;301732- 1737
Greenstein
VC, Sarter
B, Hood
D, Noble
K, Carr
R. Hue discrimination and S-cone pathway sensitivity in early diabetic retinopathy. Invest Ophthalmol Vis Sci. 1990;311008- 1014
Greenstein
VC, Shapiro
A, Hood
DC, Zaidi
Q. Chromatic and luminance sensitivity in diabetes and glaucoma. J Opt Soc Am A. 1993;101785- 1791
Mantyjarvi
M. Colour vision and dark adaptation in diabetic patients after photocoagulation. Acta Ophthalmol (Copenh). 1989;67113- 118
Greenstein
VC, Thomas
SR, Blaustein
H, Koenig
K, Carr
RE. Effects of early diabetic retinopathy on rod system sensitivity. Optom Vis Sci. 1993;7018- 23
Kinnear
PR, Aspinall
PA, Lakowski
R. The diabetic eye and colour vision. Trans Ophthalmol Soc U K. 1972;9269- 78
Lakowski
R, Aspinall
PA, Kinnear
PR. Association between colour vision losses and diabetes mellitus. Opthalmol Res. 1973;4145- 149
Adams
AJ. Chromatic and luminosity processing in retinal disease. Am J Optom Physiol Opt. 1982;59954- 960
Zisman
F, Adams
AJ. Spectral sensitivity of cone mechanisms in juvenile diabetics. Doc Ophthalmol Proc Ser. 1983;33127- 131
Roy
MS, Gunkel
RD, Podgor
MJ. Color vision defects in early diabetic retinopathy. Arch Ophthalmol. 1986;104225- 228
Moloney
J, Drury
MI. Retinopathy and retinal function in insulin-dependent diabetes mellitus. Br J Ophthalmol. 1982;66759- 761
Bresnick
GH, Condit
RS, Palta
M, Korth
K, Groo
A, Syrjala
S. Association of hue discrimination loss and diabetic retinopathy. Arch Ophthalmol. 1985;1031317- 1324
Birch-Cox
J. Defective colour vision in diabetic retinopathy before and after laser photocoagulation. Mod Probl Ophthalmol. 1978;19326- 329
Rockett
M, Anderle
D, Bessman
AN. Blue-yellow vision defects in patients with diabetes. West J Med. 1987;146431- 433
Birch
J. Colour vision changes following different types and amounts of argon laser photocoagulation in the treatment of diabetic retinopathy. Doc Ophthalmol Proc Ser. 1987;4631- 36
Lutze
M, Bresnick
GH. Lenses of diabetic patients "yellow" at an accelerated rate similar to older normals. Invest Ophthalmol Vis Sci. 1991;32194- 199
Terasaki
H, Hirose
H, Miyake
Y. S-cone pathway sensitivity in diabetes measured with threshold versus intensity curves on flashed backgrounds. Invest Ophthalmol Vis Sci. 1996;37680- 684
Tregear
SJ, Knowles
PJ, Ripley
LG, Casswell
AG. Chromatic-contrast threshold impairment in diabetes. Eye. 1997;11537- 546
Greenstein
VC, Shapiro
A, Zaidi
Q, Hood
DC. Psychophysical evidence for post-receptoral sensitivity loss in diabetics. Invest Ophthalmol Vis Sci. 1992;332781- 2790
Holopigian
K, Greenstein
VC, Seiple
W, Hood
DC, Carr
RE. Evidence for photoreceptor changes in patients with diabetic retinopathy. Invest Ophthalmol Vis Sci. 1997;382355- 2365
Gavrieli
Y, Sherman
Y, Ben-Sasson
SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992;119493- 501
Chang
GQ, Hao
Y, Wong
F. Apoptosis: final common pathway of photoreceptor death in rd, rds, and rhodopsin mutant mice. Neuron. 1993;11595- 605
Ridderstrale
Y. Intracellular localization of carbonic anhydrase in the frog nephron. Acta Physiol Scand. 1976;98465- 469
Hansson
HPJ. Histochemical demonstration of carbonic anhydrase activity. Histochemie. 1967;11112- 128
Hansson
HPJ. Histochemical demonstration of carbonic anhydrase activity in some epithelia noted for active transport. Acta Physiol Scand. 1968;73427- 434
Curcio
CA, Sloan
KR, Meyers
D. Computer methods for sampling, reconstruction, display and analysis of retinal whole mounts. Vision Res. 1989;29529- 540
Becker
B. Diabetes mellitus and primary open-angle glaucoma: the XXVII Edward Jackson Memorial Lecture. Am J Ophthalmol. 1971;11- 16
Klein
BE, Klein
R, Jensen
SC. Open-angle glaucoma and older-onset diabetes: the Beaver Dam Eye Study. Ophthalmology. 1994;1011173- 1177
Mitchell
P, Smith
W, Chey
T, Healey
PR. Open-angle glaucoma and diabetes: the Blue Mountains eye study, Australia. Ophthalmology. 1997;104712- 718
Tielsch
JM, Katz
J, Singh
K.
et al. A population-based evaluation of glaucoma screening: the Baltimore Eye Survey. Am J Epidemiol. 1991;1341102- 1110
Jonas
JB, Grundler
AE. Prevalence of diabetes mellitus and arterial hypertension in primary and secondary open-angle glaucomas. Graefes Arch Clin Exp Ophthalmol. 1998;236202- 206
Garcia-Valenzuela
E, Gorczyca
W, Darzynkiewicz
Z, Sharma
SC. Apoptosis in adult retinal ganglion cells after axotomy. J Neurobiol. 1994;25431- 438
Didenko
VV, Hornsby
PJ. Presence of double-strand breaks with single-base 3' overhangs in cells undergoing apoptosis but not necrosis. J Cell Biol. 1996;1351369- 1376
Hidayat
AA, Fine
BS. Diabetic choroidopathy: light and electron microscopic observations of seven cases. Ophthalmology. 1985;92512- 522
Cao
J, McLeod
S, Merges
CA, Lutty
GA. Choriocapillaris degeneration and related pathologic changes in human diabetic eyes. Arch Ophthalmol. 1998;116589- 597
Kurtenbach
A, Rüttiger
L, Schiefer
U, Zrenner
E, Neu
A, Heterochromatic brightness matching and wavelength discrimination in juvenile diabetics: a three-year study. Drum
B.edColour Vision Deficiencies XII Dordrecht, the Netherlands Kluwer Academic Publishers1995;47- 52
Hardy
KJ, Lipton
J, Scase
MO, Foster
DH, Scarpello
JH. Detection of colour vision abnormalities in uncomplicated type 1 diabetic patients with angiographically normal retinas. Br J Ophthalmol. 1992;76461- 464
Kurtenbach
A, Schiefer
U, Neu
A, Zrenner
E. Preretinopic changes in the colour vision of juvenile diabetics. Br J Ophthalmol. 1999;8343- 46